Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.82 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.70 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.64 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.64 |
| ▸ | HTR1A | P08908 | 3/20 | 0.62 |
| ▸ | HTR7 | P34969 | 3/20 | 0.62 |
| ▸ | DRD2 | P14416 | 2/20 | 0.62 |
| ▸ | HTR2A | P28223 | 2/20 | 0.62 |
| ▸ | HTR6 | P50406 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29739753 | 1.00 | KCNH2 (0.82) | KCNH2SIGMAR1SLC6A2SLC6A4HTR1A | |
| Hydrochloric Acid SCHEMBL1254640 | 0.98 | KCNH2 (0.80) | KCNH2SIGMAR1SLC6A2SLC6A4HTR1A | |
| SCHEMBL8121567 | 0.95 | KCNH2 (0.85) | KCNH2SIGMAR1SLC6A2SLC6A4HTR1A | |
| SCHEMBL30767216 | 0.92 | KCNH2 (0.90) | KCNH2SIGMAR1SLC6A2SLC6A4HTR1A | |
| Hydrochloric Acid SCHEMBL7658247 | 0.90 | KCNH2 (0.88) | KCNH2SIGMAR1SLC6A2SLC6A4HTR1A | |
| SCHEMBL1254408 | 0.90 | KCNH2 (0.77) | KCNH2SIGMAR1HTR1AHTR7 | |
| SCHEMBL4525555 | 0.90 | KCNH2 (1.00) | KCNH2SIGMAR1HTR1AHTR7DRD2 | |
| Hydrochloric Acid SCHEMBL8950263 | 0.88 | KCNH2 (0.65) | KCNH2SIGMAR1SLC6A2SLC6A4HTR7 | |
| SCHEMBL16939690 | 0.86 | KCNH2 (0.80) | KCNH2SIGMAR1HTR1AHTR7DRD2 | |
| SCHEMBL8957648 | 0.86 | KCNH2 (0.80) | KCNH2SIGMAR1HTR1AHTR7DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 339 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108508-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2026-04-23 | — | — | US | claimed |
| US-12221438-B2 | Continuous process for the preparation of trazodone | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2025-02-11 | — | — | US | claimed |
| US-20240139179-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2024-05-02 | — | — | US | claimed |
| CN-111886235-B | Continuous process for preparing trazodone | 方济各安吉利克化学联合股份有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-111879767-B | Color development test method of piperazine novel mental active substance | 福建警察学院 | 2022-05-03 | — | — | CN | claimed |
| CN-111795963-B | Method for chromogenic detection of piperazine novel psychotropic active substances | 福建警察学院 | 2022-05-03 | — | — | CN | claimed |
| EP-3749668-B1 | CONTINUOUS PROCESS FOR THE PREPARATION OF TRAZODONE | ACRAF (IT) | 2022-04-06 | — | — | EP | claimed |
| US-20210052577-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2021-02-25 | — | — | US | claimed |
| CN-111879767-A | Color development test method of piperazine novel mental active substance | 福建警察学院 | 2020-11-03 | — | — | CN | claimed |
| CN-111795963-A | Method for chromogenic detection of piperazine novel psychotropic active substances | 福建警察学院 | 2020-10-20 | — | — | CN | claimed |
| US-20140296250-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2014-10-02 | — | — | US | claimed |
| US-20140057922-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.P.A. (IT) | 2014-02-27 | — | — | US | claimed |
| US-20130203771-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.P.A. (IT) | 2013-08-08 | — | — | US | claimed |
| US-20130012520-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.P.A. (IT) | 2013-01-10 | — | — | US | claimed |
| US-8314236-B2 | Trazodone and trazodone hydrochloride in purified form | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2012-11-20 | — | — | US | claimed |
| US-20120142699-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.P.A. (IT) | 2012-06-07 | — | — | US | claimed |
| US-8133893-B2 | Trazodone and trazodone hydrochloride in purified form | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2012-03-13 | — | — | US | claimed |
| EP-2178850-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (IT) | 2010-04-28 | — | — | EP | claimed |
| US-20100056539-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIM. RIUM. ANG. FRANC. A.C.R.A.F.S.P.A. (IT) | 2010-03-04 | — | — | US | claimed |
| WO-2009019133-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) | 2009-02-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056539-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, OPRM1, OPRK1 | KCNH2 939/4885SIGMAR1 17/4885SLC6A2 980/4885 |
| US-20210052577-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, OPRK1, OPRM1 | KCNH2 1564/4885SIGMAR1 34/4885SLC6A2 982/4885 |
| US-12221438-B2 | Continuous process for the preparation of trazodone | CYP3A5, OPRK1, OPRD1 | KCNH2 1256/4885SIGMAR1 63/4885SLC6A2 315/4885 |
| US-20130012520-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | KCNH2 791/4885SIGMAR1 16/4885SLC6A2 1200/4885 |
| US-20140296250-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | KCNH2 791/4885SIGMAR1 16/4885SLC6A2 1200/4885 |
| US-20120142699-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | KCNH2 791/4885SIGMAR1 16/4885SLC6A2 1200/4885 |
| US-20130203771-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | KCNH2 791/4885SIGMAR1 16/4885SLC6A2 1200/4885 |
| US-20140057922-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, OPRK1, OPRM1 | KCNH2 1452/4885SIGMAR1 15/4885SLC6A2 1151/4885 |
| US-20240139179-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | OPRD1, POLL, OPRM1 | KCNH2 791/4885SIGMAR1 16/4885SLC6A2 1200/4885 |
| US-20260108508-A1 | TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM | HTR1A, HTR3A, HTR2C | KCNH2 1449/4885SIGMAR1 12/4885SLC6A2 405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.